Eventide Asset Management’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,040,000
| Closed | -$6.46M | – | 155 |
|
|
2021
Q1 | $6.46M | Sell |
1,040,000
-80,000
| -7% | -$497K | 0.1% | 126 |
|
|
2020
Q4 | $8.34M | Hold |
1,120,000
| – | – | 0.13% | 112 |
|
|
2020
Q3 | $6.79M | Hold |
1,120,000
| – | – | 0.13% | 107 |
|
|
2020
Q2 | $9.35M | Buy |
1,120,000
+400,000
| +56% | +$3.34M | 0.2% | 96 |
|
|
2020
Q1 | $4.28M | Hold |
720,000
| – | – | 0.14% | 93 |
|
|
2019
Q4 | $4.67M | Hold |
720,000
| – | – | 0.13% | 83 |
|
|
2019
Q3 | $3.46M | Hold |
720,000
| – | – | 0.11% | 86 |
|
|
2019
Q2 | $2.88M | Hold |
720,000
| – | – | 0.09% | 93 |
|
|
2019
Q1 | $3.49M | Hold |
720,000
| – | – | 0.12% | 95 |
|
|
2018
Q4 | $4.59M | Sell |
720,000
-21,175
| -3% | -$135K | 0.2% | 87 |
|
|
2018
Q3 | $6.08M | Hold |
741,175
| – | – | 0.22% | 97 |
|
|
2018
Q2 | $7.74M | Hold |
741,175
| – | – | 0.32% | 83 |
|
|
2018
Q1 | $8.96M | Hold |
741,175
| – | – | 0.42% | 67 |
|
|
2017
Q4 | $7.39M | Buy |
+741,175
| New | +$7.39M | 0.39% | 67 |
|